Schott Pharma AG KGaA (XTER:1SXP) EV-to-EBIT : 22.48 (As of May. 31, 2024)

Schott Pharma AG KGaA EV-to-EBIT Chart

Competitive Comparison of Schott Pharma AG KGaA's EV-to-EBIT

For the Medical Instruments & Supplies subindustry, Schott Pharma AG KGaA's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Schott Pharma AG KGaA's EV-to-EBIT Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Schott Pharma AG KGaA's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Schott Pharma AG KGaA's EV-to-EBIT falls into.

Schott Pharma AG KGaA EV-to-EBIT Calculation

Schott Pharma AG KGaA's EV-to-EBIT for today is calculated as:

Schott Pharma AG KGaA's current Enterprise Value is €4,339.0 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Schott Pharma AG KGaA's EBIT for the trailing twelve months (TTM) ended in Sep. 2023 was €193.1 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Schott Pharma AG KGaA  (XTER:1SXP) EV-to-EBIT Explanation

This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %.

Schott Pharma AG KGaA's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Sep. 2023 is calculated as:

Schott Pharma AG KGaA's Enterprise Value for the quarter that ended in Sep. 2023 was €4,813.6 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Schott Pharma AG KGaA's EBIT for the trailing twelve months (TTM) ended in Sep. 2023 was €193.1 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Schott Pharma AG KGaA EV-to-EBIT Related Terms

Thank you for viewing the detailed overview of Schott Pharma AG KGaA's EV-to-EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.

Schott Pharma AG KGaA (XTER:1SXP) Business Description